Mark R. Goldston - Nov 13, 2024 Form 4 Insider Report for Beachbody Company, Inc. (BODY)

Role
Executive Chairman, Director
Signature
/s/ Jonathan Gelfand, Attorney-in-Fact for Mark R. Goldston
Stock symbol
BODY
Transactions as of
Nov 13, 2024
Transactions value $
$0
Form type
4
Date filed
11/15/2024, 05:52 PM
Previous filing
Jun 20, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BODY Stock Option (Right to Buy Class A Common Stock) Disposed to Issuer $0 -318K -100% $0.00 0 Nov 13, 2024 Class A Common Stock 318K $22.02 Direct F1, F2, F3
transaction BODY Stock Option (Right to Buy Class A Common Stock) Disposed to Issuer $0 -159K -100% $0.00 0 Nov 13, 2024 Class A Common Stock 159K $22.02 Direct F2, F3, F4
transaction BODY Stock Option (Right to Buy Class A Common Stock) Award $0 +478K $0.00 478K Nov 13, 2024 Class A Common Stock 478K $6.43 Direct F1, F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a modification by the Company's board on September 19, 2024 of a portion of the stock option previously granted on June 15, 2023 to convert the option from vesting based on achieving specified stock price goals to time-based vesting commencing with the June 15, 2023 original grant date, subject to continued service with the Company on the applicable vesting dates, effective as of November 13, 2024.
F2 Represents a modification by the Company's board on September 19, 2024 of the stock option previously granted on June 15, 2023 to reprice the option exercise price, reflected herein as a cancellation of the old option with an exercise price of $22.02 in exchange for a new option with an exercise price of $6.43, based on the closing price of the Company's common stock on the November 13, 2024 effective date of the repricing.
F3 Reflects the total number of shares subject to the option and the exercise price after giving effect to the Company's 1-for-50 reverse stock split effective on November 21, 2023.
F4 The option vests and becomes exercisable with respect to 25% of the shares subject to the option on each of the first four anniversaries of June 15, 2023, subject to the Reporting Person's continued service with the Company through the applicable vesting date.